177 related articles for article (PubMed ID: 36123698)
1. Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression.
Sun T; Zhang K; Li W; Liu Y; Pangeni RP; Li A; Arvanitis L; Raz DJ
Cell Commun Signal; 2022 Sep; 20(1):147. PubMed ID: 36123698
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer.
Zhang K; Yang L; Wang J; Sun T; Guo Y; Nelson R; Tong TR; Pangeni R; Salgia R; Raz DJ
Cell Commun Signal; 2019 Dec; 17(1):167. PubMed ID: 31842906
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of ubiquitin-specific protease 22 predicts poor survival in patients with early-stage non-small cell lung cancer.
Ning J; Zhang J; Liu W; Lang Y; Xue Y; Xu S
Eur J Histochem; 2012 Nov; 56(4):e46. PubMed ID: 23361242
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.
Xu G; Cai J; Wang L; Jiang L; Huang J; Hu R; Ding F
Exp Cell Res; 2018 Jan; 362(2):268-278. PubMed ID: 29174979
[TBL] [Abstract][Full Text] [Related]
5. USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition.
Ding F; Bao C; Tian Y; Xiao H; Wang M; Xie X; Hu F; Mei J
Int J Mol Sci; 2014 Dec; 16(1):307-20. PubMed ID: 25547493
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of the human USP22 gene promoter.
Xiong J; Che X; Li X; Yu H; Gong Z; Li W
PLoS One; 2012; 7(12):e52716. PubMed ID: 23300749
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells.
Zhang K; Sun T; Li W; Guo Y; Li A; Hsieh M; Wang J; Wu J; Arvanitis L; Raz DJ
Cell Commun Signal; 2023 Nov; 21(1):319. PubMed ID: 37946202
[TBL] [Abstract][Full Text] [Related]
9. USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer.
Xiao H; Tian Y; Yang Y; Hu F; Xie X; Mei J; Ding F
Biochem Biophys Res Commun; 2015 May; 460(3):703-8. PubMed ID: 25817787
[TBL] [Abstract][Full Text] [Related]
10. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells.
Gennaro VJ; Stanek TJ; Peck AR; Sun Y; Wang F; Qie S; Knudsen KE; Rui H; Butt T; Diehl JA; McMahon SB
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9298-E9307. PubMed ID: 30224477
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
12. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
[TBL] [Abstract][Full Text] [Related]
13. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.
Zhang XY; Varthi M; Sykes SM; Phillips C; Warzecha C; Zhu W; Wyce A; Thorne AW; Berger SL; McMahon SB
Mol Cell; 2008 Jan; 29(1):102-11. PubMed ID: 18206973
[TBL] [Abstract][Full Text] [Related]
14. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.
Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L
Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317
[TBL] [Abstract][Full Text] [Related]
15. Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth.
Xu H; Liu YL; Yang YM; Dong XS
Int J Colorectal Dis; 2012 Jan; 27(1):21-30. PubMed ID: 21773699
[TBL] [Abstract][Full Text] [Related]
16. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
17. Knock-down of USP22 by small interfering RNA interference inhibits HepG2 cell proliferation and induces cell cycle arrest.
Ling SB; Sun DG; Tang B; Guo C; Zhang Y; Liang R; Wang LM
Cell Mol Biol (Noisy-le-grand); 2012 Dec; 58 Suppl():OL1803-8. PubMed ID: 23217440
[TBL] [Abstract][Full Text] [Related]
18. MiR-30e-5p inhibits proliferation and metastasis of nasopharyngeal carcinoma cells by target-ing USP22.
Ma YX; Zhang H; Li XH; Liu YH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6342-6349. PubMed ID: 30338802
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
[TBL] [Abstract][Full Text] [Related]
20. Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.
Guo J; Zhao J; Fu W; Xu Q; Huang D
Front Immunol; 2022; 13():918314. PubMed ID: 35935969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]